Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study

Published on: 
,
Pharmaceutical Technology, Pharmaceutical Technology-05-15-2015, Volume 2015 eBook, Issue 2

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

 

Advertisement

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

Download


 

Related Content:

Aseptic/Sterile ProcessingBiologic DrugsManufacturingDosage FormsManufacturing, Parenterals and InjectablesManufacturing, LyophilizationPharmaceutical Technology-05-15-2015
Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)
Improving ADC Manufacture Means Stricter Containment Requirements and Continuous Advancement of Analytics (INTERPHEX 2024)
Disinfection of Manufacturing Environments: Balancing Efficacy and Cost of Cleaning with Safety and Environmental Impact (INTERPHEX 2024)